| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d60813bf897ef5a62663bc9e6ef135ca |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-136 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2012-10-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_55b588c0c11b794b1309386ca09b94c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a15bfddc9b8b19162dc9e08a709c169
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78ea331b9ce29d46df176acfb8e2e7f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5480210c441216f8a6585a0c59e627db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8288a272eeda4e3ba8f278c7f4f6bdd0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_339ee23ffa484fc6402e64ede97f6077
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b02b048ca2f05d47d8a06764479b62c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_00adaf1ae0452f6aa1f39efcbb55c241
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_36f6a2ccb8fadd1295481991d7290a78
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53a5b96dbbfc0c283a07261296b41bad |
| publicationDate |
2013-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2013096212-A1 |
| titleOfInvention |
Method and a Kit to Predict Response to Antidepressant Treatment |
| abstract |
The present invention relates to the method for predicting the pharmacoresponse of antidepressants in patients diagnosed with major depression and panic disorder. According to the invention, SNP (rs41271330) in the coding region of the BMP5 gene together with the markers in linkage disequilibrium with this SNP could be used as predictors of SSRI treatment efficacy. The knowledge obtained by using the method disclosed in present invention has potential to increase the efficacy of pharmacological treatment in patients with major depression and panic disorder. The invention also provides a kit for detecting individual who are likely to respond to antidepressant treatment. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023082401-A1 |
| priorityDate |
2011-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |